Provider review
ClickSlim review
The standing price depends on the size of the screen you're reading it on.
A phone visitor and a laptop visitor are quoted different standing rates for the same program. Neither figure has a dose attached to it. And the microdose page is sold as maintenance after you finish, not as a way in.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
ClickSlim
$349/mo standing on desktop, $299 on mobile
- Vs median
- $180/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
You cannot find out what a quarter dose costs here, because no milligram figure appears against any price. Worse, there is no single price to find: the homepage quotes one standing rate on a phone and a higher one on a laptop, for the same program, and the gap is real money every month. Give ClickSlim credit for two things. It prints the step-down after the introductory offer rather than showing only the teaser, so the recurring rate is at least stated wherever you see it. And its microdose page is honest — it treats microdosing as maintenance after goal weight rather than a cheap way in, and openly offers a medication-free path instead. Two more things will cost you. The site's own Pricing nav item leads to a page that isn't there. And its NAD+ card is labeled as containing tirzepatide, which it does not.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the post-introductory rate stated up front rather than discovered on the second bill.
- You have already reached your goal and want a maintenance protocol rather than a cheaper way to start.
- You are buying tirzepatide and do not need a milligram figure to decide.
Look elsewhere if
- You are taking less to spend less. No dose sits behind any price here, so there is nothing to compare.
- You are comparing quotes between devices. The rate you were shown may not be the rate anyone else was shown.
- You want semaglutide. The word does not appear on the pricing or product pages.
- You want the dispensing pharmacy named, or your state confirmed before you order.
What it actually costs
Price as published
$349/month standing on desktop, tablet and widescreen · $299/month standing on mobile — the homepage publishes two different standing rates depending on the breakpoint you view it at, a $50/month gap decided by the device in your hand · introductory first month $299 (desktop) or $249 (mobile) · GLP-1 + NAD bundle "$498 then $548 per month, NAD+ discounted to $199" (desktop) or "$199/month then $448 per month, Standalone NAD+ $249.00" (mobile) · no prepay rungs published · billing is "per month" with no more precise cycle · the "Simple, Transparent Pricing" cards say "Starting at $299" for GLP-1/GIP, which is the introductory rate and not the standing one
- Vs median
- $180/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The row records no published dose behind any figure, so the dose-to-price relationship cannot be established in either direction. It also records that the standing rate itself is not single-valued — the homepage quotes one rate to desktop visitors and a lower one to phone visitors for the same program — so there is no stable figure for a dose to be compared against. A microdose page exists but carries no price and is positioned as post-goal maintenance rather than as a low-dose entry point.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Publishes the step-down after the introductory offer — "Special introductory offer $299/month then $349 per month" — rather than showing only the teaser rate
- Its microdose page is honest that microdosing is a maintenance option after goal weight rather than a cheap entry point, and openly offers a medication-free maintenance path instead
- Names a specific clinician rather than gesturing at a provider network
- Prices the NAD+ bundle and the standalone NAD+ product alongside the GLP-1 program rather than quoting them on request
Pharmacy, labs and oversight
ClickSlim does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What ClickSlim publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
ClickSlim sells a compounded tirzepatide program as a weekly injection, priced entirely on its homepage with an introductory first month and a stated step-up afterwards. Semaglutide does not appear on the homepage or on the GLP-1/GIP product page at all. A separate microdose page positions low dosing strictly as post-goal maintenance rather than as an entry point, alongside a medication-free maintenance option. The named clinician is Dr. Nichola Patton, AGACNP, and the operating address is a registered-agent suite in Sheridan, Wyoming.
The honest cons
THE HOMEPAGE PRICES DIFFER BY SCREEN SIZE. Desktop, tablet and widescreen visitors see a standing rate of $349/month; phone visitors see $299/month for the same program — the two are quoted $50/month apart
- NO MILLIGRAM FIGURE IS PUBLISHED AGAINST ANY PRICE, so the dose behind the rate cannot be known before purchase
- Two further pricing blocks — "$349/month then $399" and "$549/month then $599" — sit in the page hidden at every breakpoint, so they render to nobody
- clickslim.com/pricing, the destination of the site's own Pricing nav item, does not resolve (checked 2026-08-10)
- The "Simple, Transparent Pricing" cards quote "Starting at $299" for GLP-1/GIP, which is the introductory rate rather than the standing one
- The NAD+ card is labeled "*CONTAINS TIRZEPATIDE" — NAD+ does not contain tirzepatide; the label is copied from the GLP-1 cards
- The product page /personalized-glp-gip/ publishes no price at all; every figure lives on the homepage
- Whether semaglutide is sold at all is unclear — the word appears nowhere on the homepage or the GLP-1/GIP product page
- States served are not published — only "Our services are available in most States"
- No compounding pharmacy is named — "ClickSlim is not a pharmacy … medications are dispensed by appropriately licensed pharmacies"
- The operating address is a registered-agent suite in Sheridan, Wyoming (1309 Coffeen Ave, Ste 12846)
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
ClickSlim is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#86 of 373
Ordered with the companies that pay us first, and ClickSlim is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.